BXN · ASX

Bioxyne Limited (ASX:BXN)

AU$0.025

 0.001 (4.167%)
ASX:Live
16/05/2025 04:10:19 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BXN Overview

BXN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About BXN

Website

N/A

Telephone

61.2.9078.8180

Address

Suite 506, Level 5 50 Clarence Street Sydney, New South Wales (NSW) 2000

Description

Bioxyne Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.

BXN Price Chart

Key Stats

Market Cap

AU$51.96M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.05

Trade Value (12mth)

AU$12,870.00

1 week

-4%

1 month

0%

YTD

-11.11%

1 year

300%

All time high

8.93

Key Fundamentals

EPS 3 yr Growth

762.50%

EBITDA Margin

-15.00%

Operating Cashflow

-$4m

Free Cash Flow Return

-37.00%

ROIC

-133.10%

Interest Coverage

N/A

Quick Ratio

1.20

Other Data

Shares on Issue (Fully Dilluted)

2096m

HALO Sector

Industrials

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BXN Announcements

Latest Announcements

Date Announcements

30 April 25

Invitation to Investor Webinar 1 May 2025 at 4PM AEST

×

Invitation to Investor Webinar 1 May 2025 at 4PM AEST

28 April 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

07 April 25

Notification regarding unquoted securities - BXN

×

Notification regarding unquoted securities - BXN

07 April 25

Notification regarding unquoted securities - BXN

×

Notification regarding unquoted securities - BXN

07 April 25

Notification regarding unquoted securities - BXN

×

Notification regarding unquoted securities - BXN

03 April 25

BXN Signs Exclusive $7m Manufacturing and Supply Agreement

×

BXN Signs Exclusive $7m Manufacturing and Supply Agreement

03 April 25

Prof Michael Barnes MD, FRCP Joins BXN Advisory Board

×

Prof Michael Barnes MD, FRCP Joins BXN Advisory Board

27 March 25

Application for quotation of securities - BXN

×

Application for quotation of securities - BXN

27 March 25

Cleansing Notice

×

Cleansing Notice

21 March 25

Bioxyne Raises A$3 million in Capital Raise

×

Bioxyne Raises A$3 million in Capital Raise

21 March 25

Proposed issue of securities - BXN

×

Proposed issue of securities - BXN

21 March 25

Proposed issue of securities - BXN

×

Proposed issue of securities - BXN

21 March 25

Proposed issue of securities - BXN

×

Proposed issue of securities - BXN

19 March 25

Pause in Trading

×

Pause in Trading

19 March 25

Trading Halt

×

Trading Halt

04 March 25

Bioxyne Investor Webinar 5 March

×

Bioxyne Investor Webinar 5 March

28 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

28 February 25

BXN H1 FY25 Results Presentation

×

BXN H1 FY25 Results Presentation

28 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 January 25

Quarterly Activities Report December 2024 Revised

×

Quarterly Activities Report December 2024 Revised

23 January 25

Revenue Guidance

×

Revenue Guidance

14 January 25

Addendum to Presentation dated 18 November 2024

×

Addendum to Presentation dated 18 November 2024

19 December 24

Notification regarding unquoted securities - BXN

×

Notification regarding unquoted securities - BXN

19 December 24

Notification of cessation of securities - BXN

×

Notification of cessation of securities - BXN

19 December 24

Notification regarding unquoted securities - BXN

×

Notification regarding unquoted securities - BXN

BXN Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.5 -100.0 -392.9 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -390.6 74.3 19.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -6.4 -4.4 -38.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock -0.00 0.01 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -197.6 166.5 -13.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 732 1,344 1,930 Lock Lock Lock
Basic m Lock Lock Lock Lock 732 1,344 1,930 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 5 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -78.0 1,011.7 80.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 0 2 3 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -135.0 40.3 1,374.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -48.3 -2.6 18.3 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 148 103 82 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 0 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.7 -346.6 26.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -91.4 -36.7 -15.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 0 -2 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.6 -340.5 17.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -98.0 -38.8 -17.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 0 -2 -13 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 0 -2 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 0.3 -292.7 -585.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -106.6 -37.6 -142.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 -1 -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 4 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -1 -1 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1,167.0 -109.9 -214.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.2 -0.2 -0.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 0 4 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 0 18 7 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 0 -4 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 3 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 0 15 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 0 15 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -119.4 4,248.9 -72.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -110.9 -11.0 -198.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 135.4 -12.8 -368.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -57.9 -27.3 -17.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -65.2 -25.6 -133.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -66.9 -15.3 -37.0 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.2 2.0 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 18.1 -25.4 -9.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.5 2.2 1.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.4 1.9 1.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 16.4 63.7 18.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -62.2 -42.1 -122.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.5 8.2 7.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 3.1 9.9 4.9 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 1.5 3.5 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 44.0 23.4 12.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.0 0.3 1.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.0 0.3 1.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -106.6 -38.6 -142.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -110.9 -11.2 -198.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -110.9 -11.0 -198.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock -1.2 1.2 1.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 135.4 -12.8 -368.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 135.4 -12.8 -368.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 118.1 36.9 75.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 250.0 44.7 51.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 368.1 81.6 127.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 100.8 48.6 49.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 267.3 33.0 77.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BXN Shortsell

Frequently Asked Questions

The current share price of Bioxyne Limited (BXN:ASX) is AU$0.025.
The 52-week high share price for Bioxyne Limited (BXN:ASX) is AU$0.05.
The 52-week low share price for Bioxyne Limited (BXN:ASX)? is AU$0.00.
Bioxyne Limited (BXN:ASX) does not pay a dividend.
Bioxyne Limited (BXN:ASX) does not pay a dividend.
Bioxyne Limited (BXN:ASX) has a franking level of 0.0%.
Bioxyne Limited (BXN:ASX) is classified in the Industrials.
The current P/E ratio for Bioxyne Limited (BXN:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.